Diagnosis and management of chronic ITP: comments from an ICIS expert group.
Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.
Grainger
John David
JD
, Manchester, UK, John.Grainger@cmft.nhs.uk.
Bolton-Maggs
Paula H B
PH
Godeau
Bertrand
B
Bussel
Jim
J
Donato
Hugo
H
Elalfy
Mohsen
M
Hainmann
Ina
I
Matzdorff
Axel
A
Müller-Beissenhirtz
Hannes
H
Rovó
Alicia
A
Tichelli
Andre
A
D000328:Adult; D016824:Antigens, Human Platelet / Q000276:immunology; D015551:Autoimmunity; D001853:Bone Marrow / Q000276:immunology / Q000503:physiopathology; D002648:Child; D002908:Chronic Disease; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*
D016824:Antigens, Human Platelet